Navigation Links
Prix Galien USA Announces 2008 Final Candidates

Honorees for best pharmaceutical agent and best biotechnology product to be recognized at Sept. 24 gala ceremony

NEW YORK, Aug. 12 /PRNewswire-USNewswire/ -- The Prix Galien USA 2008 ( will recognize innovative biopharmaceutical drugs and devices that have made a deep impact on the quality of human life in ways that range from providing treatment for cancer and HIV/AIDS to hypertension and chronic pain. Charlie Rose will again emcee the awards ceremony on September 24, 2008, to be held at the American Museum of Natural History in New York.

The final candidates for the Prix Galien USA 2008 awards are:

-- Actelion Ltd. - Ventavis(R) (Iloprost)

-- Alexion Pharmaceuticals - Soliris(TM)

-- BioMarin Pharmaceutical Inc. - Nagalzyme(R)

-- Bristol-Myers Squibb - Sprycel(R)

-- Boehringer Ingelheim - Aptivus(R) and Spiriva(R)

-- Celgene Corporation - Revlimid(R)

-- CV Therapeutics Inc. - Ranexa(R) (ranolazine)

-- Elan Corporation - Prialt(R) (ziconotide intrathecal infusion)

-- Eli Lilly Company - Evista(R) raloxifene HCI

-- Genzyme Corporation - Myozyme(R)

-- GlaxoSmithKline - Tykerb(TM) (lapatinib) and Altabax(TM) (retapamulin ointment)

-- Merck & Co. - Isentress(R) (raltegravir)

-- Novartis AG - Exjade(R) (deferasirox) and Tekturna(R)

-- Nycomed - Omnaris

-- Pfizer Inc. - Selzentry(TM)

-- Roche Laboratories Inc. - Boniva(R)

-- sanofi-aventis - Lovenox(R)

-- Sanofi Pasteur - H5N1 influenza virus vaccine

-- Sucampo Pharmaceuticals, Inc. - Amitiza(R)

-- Wyeth - Infuse/InductOs (rh BMP-2 dibotermin alfa) Torisel (temsirolimus) Injection.

"Nominees for the Prix Galien USA stand apart from other drugs in the marketplace for the amount of research and level of skill that was invested to develop these innovative medicines that improve lives," said Gerald Weissmann, M.D., Prix Galien USA committee chair, New York University professor emeritus and editor-in-chief of The FASEB Journal.

At the awards ceremony The Population Council and Sheldon Segal, distinguished scientist at the organization, will receive the Prix Galien USA 2008 Pro Bono Humanum Award along with other members of the coalition -- Wyeth, Dow Corning and the late Judah Folkman of Harvard University -- that made possible the development and distribution of implantable hormone delivery systems that are used for birth control and family planning purposes by more than 8 million women worldwide.

The Prix Galien USA Awards ( committee of 11, including 7 Nobel Laureates, recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines that improve the human condition, and is considered the industry's highest accolade for pharmaceutical research and development -- equivalent to the Nobel Prize.

SOURCE Prix Galien USA
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
2. Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
3. Bion Announces Approval of New U.S. Patent for Phosphorus Removal Process for Livestock Waste Environmental Treatment
4. Telik Announces Financial Results For 2008 Second Quarter
5. Mergent, Inc. Announces Changes to the HealthShares(TM) European Drugs Index
6. GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update
7. Genaera Corporation Announces Second Quarter Financial Results
8. China Biologic Products Announces Second Quarter 2008 Results Conference Call
9. Huifeng Bio-Pharmaceutical (HFGB) Announces USD $1.1 Million Supply Agreement with DNP International Co. Inc.
10. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
11. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
Post Your Comments:
(Date:6/27/2016)... , June 27, 2016  Global demand for ... percent through 2020 to $7.2 billion.  This market ... beverages, cleaning products, biofuel production, animal feed, and ... diagnostics, and biocatalysts). Food and beverages will remain ... by increasing consumption of products containing enzymes in ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... on what they believe could be a new and helpful biomarker for malignant ... Click here to read it now. , Biomarkers are components in ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... for Amgen, will join the faculty of the University of North Carolina ... professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the ...
(Date:6/24/2016)... on a range of subjects including policies, debt and investment ... Speaking at a lecture to the Canadian Economics ... the country,s inflation target, which is set by both the ... "In certain areas there needs to be frequent ... not sit down and address strategy together?" He ...
Breaking Biology Technology:
(Date:5/12/2016)... -- , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... subsidiary of Infosys (NYSE: INFY ), and Samsung ... global partnership that will provide end customers with a ... and payment services.      (Logo: ... for financial services, but it also plays a fundamental part ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
Breaking Biology News(10 mins):